Armin Reininger
Corporate Officer/Principal en SWEDISH ORPHAN BIOVITRUM AB .
Fortuna: 435 072 $ al 30/04/2024
Cargos activos de Armin Reininger
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | 06/01/2017 | - |
| Director Técnico/Científico/I+D | 06/01/2017 | - |
Historial de carrera de Armin Reininger
Antiguos cargos conocidos de Armin Reininger.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BAXALTA INC | Director Técnico/Científico/I+D | - | - |
| Corporate Officer/Principal | - | - | |
| Ludwig-Maximilians-Universität München | Corporate Officer/Principal | - | - |
Formación de Armin Reininger.
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Estadísticas
Internacional
| Suecia | 2 |
| Alemania | 2 |
| Estados Unidos | 2 |
Operativa
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| Empresas privadas | 1 |
|---|---|
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
- Bolsa de valores
- Insiders
- Armin Reininger
- Experiencia